November 6, 2023
Northfield, NH – EPTAM Precision Solutions (“EPTAM” or the “Company”), a Frazier Healthcare Partners (“Frazier”) portfolio company, is pleased to announce the appointment of Graham Schillmoller as its new Chief Financial Officer (CFO), effective October 9th. As a key addition to EPTAM’s leadership team, Graham will play a crucial role in driving EPTAM’s continued growth and financial excellence.
Founded in 1981, EPTAM is an outsourced manufacturer of medical device components and finished devices. EPTAM’s services include manufacturing implants, minimally invasive surgical instruments, interventional and structural heart components, single-use medical disposables, biopharma processing equipment components and molecular diagnostic testing cartridges, as well as other high-precision surgical device components. The Company has expertise with polymer machining, precision metal machining, injection molding, liquid silicon rubber molding, laser cutting/welding, and metal injection molding. Additionally, EPTAM offers a wide range of value-added services such as process validation, design-for-assembly, cleanroom assembly, laser cutting/welding equipment development, process development, rapid-prototyping, and technical program management. EPTAM has over 650 employees with operations in New Hampshire, Massachusetts, New Jersey, Connecticut, Michigan, Minnesota, and Colorado.
Graham spent the last eighteen years of his career at Parata Systems, a former Frazier Healthcare Partners portfolio company, where he oversaw its significant growth from a start-up company to a fully mature and highly successful company. During his tenure, Graham experienced progressive growth in multiple roles from Controller to CFO, and led the following teams: Financial Planning & Analysis, Accounting, Legal & Risk Management, Manufacturing, Supply Chain, and Information Technology. His achievements include overseeing and integrating seven acquisitions across three countries and playing a key role on the team that sold Parata Systems to Becton Dickinson in 2022. His background in working as CFO at a Frazier Healthcare Partners portfolio company will serve him well in his role with EPTAM.
“In Graham Schillmoller, EPTAM has found a seasoned financial executive with a proven track record of leadership while scaling and driving rapid growth. Graham’s success with Parata Systems over the last 18 years, a company that brought automated pharmacy solutions to market, is a testament to his business acumen and executive leadership” stated Mark Kemp, CEO of EPTAM Precision Solutions. “With more than 25 years of experience in corporate accounting, financial management, and creating technology solutions for the healthcare industry, Graham brings a wealth of knowledge and expertise that will be instrumental in guiding EPTAM through its next phase of growth.”
In his new role as CFO, Graham will be responsible for Financial Planning & Analysis, Accounting, Tax, Legal & Risk Management, Corporate Development, and Information Technology. His strong financial acumen and strategic vision will be vital as we work to achieve our strategic growth initiatives.
Graham added, “I am thrilled to join the EPTAM team and be a part of such a dynamic and innovative organization. I look forward to contributing to EPTAM’s growth and financial strength and working closely with our dedicated team to achieve our strategic goals.”
About EPTAM Precision Solutions
EPTAM is a leading high-precision outsourced manufacturer of complex components and devices with particular expertise in plastic, metal, and injection molded applications. The company provides its custom machining solutions to leaders in the Medical Devices, BioPharma, and Diversified Industrials sectors. Please visit (www.eptam.com) for more details about the company and its diverse portfolio of services.
About Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a leading private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $8 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 32 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier is headquartered in Seattle, WA, and invests broadly across the U.S., Canada, and Europe. For more information about Frazier, visit www.frazierhealthcare.com/growth-buyout.